Table 2 Relationship between clinicopathological parameters and lymph node density in 88 patients with lymph node-positive cervical cancer
From: The impact of lymph node density on survival of cervical cancer patients
LND ⩽10% ( n =36) | LND >10% ( n =52) | P -value a | |
|---|---|---|---|
Tumour stage | 0.03 | ||
FIGO I | 18/30 (60.0%) | 12/30 (40.0%) | |
FIGO II | 13/45 (28.8%) | 32/45 (71.2%) | |
FIGO III and IV | 5/13 (38.5%) | 8/13 (31.5%) | |
Age at first diagnosis | 0.2 | ||
<50 years | 22/48 (45.8%) | 26/48 (54.2%) | |
⩾50 years | 14/40 (35.0%) | 36/52 (65.0%) | |
Histological grade | 0.8 | ||
G1 | 2/6 (33.3%) | 4/6 (66.7%) | |
G2 | 20/46 (43.5%) | 26/46 (56.5%) | |
G3 | 11/30 (36.7%) | 19/30 (63.3%) | |
Histological type | 0.5 | ||
Squamous cell carcinoma | 28/71 (39.4%) | 43/71 (60.6%) | |
Adenosquamous carcinoma | 7/16 (43.8%) | 9/16 (56.2%) | |
